Here's Why Covista (CVSA) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research9/23/2026Positive
CVSA
Covista Inc.NYSECONSUMER DEFENSIVEEDUCATION & TRAINING SERVICES
Key Statistics
Market Cap
$4.23B
P/E Ratio
16.45
EPS
$7.55
Beta
0.63
52W High
$156.26
52W Low
$86.97
50-Day MA
$127.22
200-Day MA
$116.67
Dividend Yield
—
Profit Margin
12.90%
Forward P/E
13.61
PEG Ratio
0.91
About Covista Inc.
Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.
Fundamentals
| Revenue (TTM) | $1.95B |
| Gross Profit (TTM) | $1.12B |
| EBITDA | $444.77M |
| Operating Margin | 19.30% |
| Return on Equity | 18.60% |
| Return on Assets | 8.45% |
| Revenue/Share (TTM) | $55.76 |
| Book Value | $42.49 |
| Price-to-Book | 2.90 |
| Price-to-Sales (TTM) | 2.16 |
| EV/Revenue | 2.457 |
| EV/EBITDA | 10.28 |
| Quarterly Earnings Growth (YoY) | 43.20% |
| Quarterly Revenue Growth (YoY) | 9.70% |
| Shares Outstanding | $34.04M |
| Float | $33.14M |
| % Insiders | 2.74% |
| % Institutions | 103.26% |
Historical Volatility
HV 10-Day
19.93%
HV 20-Day
28.96%
HV 30-Day
30.28%
HV 60-Day
55.82%
HV Rank
28.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($159.50 target)
1
Strong Buy3
BuyLatest News
Covista (CVSA) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research9/16/2026Positive
Chamberlain University to Open Nashville Campus; Now Accepting Applications for January 2027 Cohort
NASHVILLE--(BUSINESS WIRE)--Chamberlain University, America's largest school of nursing and a Covista (NYSE: CVSA) institution, today announced it will open a new campus in Nashville, Tennessee, its first location in the state. The campus continues Chamberlain's national expansion strategy to address the U.S. healthcare workforce shortage and will offer day, evening and weekend class options, giving students more flexible opportunities to pursue a nursing degree. The university will begin accep.
Business Wire9/9/2026Neutral
Covista to Participate in September Investor Conferences
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, announced today that it will participate in two investor conferences this September: Jefferies Healthcare Services and Technology Conference: Steve Beard, Chairman and Chief Executive Officer, Covista, and Bob Phelan, Chief Financial Officer, Covista, will present at the conference in Nashville, Tennessee, on Monday, September 14, 2026, at 9:10 a.m. CT. The fireside chat will be available via webcast and repl.
Business Wire9/8/2026Neutral
Here's Why Covista (CVSA) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research9/3/2026Positive
Here's Why Covista (CVSA) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research8/27/2026Positive
Here's Why Covista (CVSA) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/17/2026Positive
Covista: Strong Secular Growth And Operating Leverage
Covista is rated BUY, driven by secular healthcare education demand and 12 consecutive quarters of enrollment growth. CVSA's Q4 saw revenue up 9.7% and adjusted EPS up 25.9%, with all segments showing positive operating leverage and margin expansion. Strong cash flows, a declining leverage ratio, and $238m in share repurchases reinforce balance sheet strength and shareholder returns.
Seeking Alpha8/14/2026Positive
Why Covista (CVSA) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/10/2026Positive
Covista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y
CVSA posts double-digit profit growth, record Walden enrollment and raises fiscal 2027 targets as strong execution continued across all three segments.
Zacks Investment Research8/7/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CVSA and any ticker you trade — then tracks every position and per-strategy win rate.
More CONSUMER DEFENSIVE Stocks
Data last updated: 9/26/2026